Ligand-dependent repression of nuclear receptor activity forms a novel mechanism for regulating gene expression. To investigate the intrinsic role of the corepressor RIP140, we have monitored gene expression profiles in cells that express or lack the RIP140 gene and that can be induced to undergo adipogenesis in vitro. In contrast to normal white adipose tissue and in vitro-differentiated wild-type adipocytes, RIP140-null cells show elevated energy expenditure and express high levels of the uncoupling protein 1 gene (Ucp1), carnitine palmitoyltransferase 1b, and the cell-death-inducing DFF45-like effector A. Conversely, all these changes are abrogated by the reexpression of RIP140. Analysis of the Ucp1 promoter showed RIP140 recruitment to a key enhancer element, demonstrating a direct role in repressing gene expression. Therefore, reduction in the levels of RIP140 or prevention of its recruitment to nuclear receptors may provide novel mechanisms for the control of energy expenditure in adipose cells.
The adipocyte plays an active and fundamental role in energy homeostasis, and adipose tissue is central in many of the pathologies associated with obesity (10, 22, 36) . Adipocyte functions include the processes of lipid metabolism, glucose metabolism, and endocrine secretion of hormones and cytokines. Two types of adipose tissue, white adipose tissue (WAT) and brown adipose tissue (BAT), have been described. This classification is based on morphological and histological factors as well as a number of characteristic biochemical processes that are controlled in part by the activation of the sympathetic nervous system (2, 7, 25) . In addition, genetic factors play a major role in the control of energy balance, and genes that regulate adipose tissue mass have been identified and may be implicated in the differentiation of white and brown adipose cells (5, 11, 24, 26, 38) .
One of the key genes in BAT (Ucp1) encodes uncoupling protein 1, a member of the mitochondrial carrier family of proteins. Upon Ucp1 activation, respiration is uncoupled from ATP synthesis, resulting in an increased metabolic rate and the release of chemical energy from the brown fat in the form of heat (8) . Functionally defective BAT has been associated with obesity (9, 12) , and transgenic mice with reduced BAT are obese, with symptoms of hyperglycemia and insulin resistance (21) . In addition, ectopic expression of Ucp1 in WAT in transgenic mice results in resistance to diet-induced obesity and diabetes (15) . Thus, the amount of BAT and the expression of Ucp1 correlate with protection from obesity.
Adipose tissue is controlled by humoral factors, by para-and intracrine factors, and by neural regulation. The differentiation of direct effects from systemic effects following genetic manipulation requires the analysis of in vitro and in vivo systems. Cell culture systems provide the opportunity to study the cell-autonomous action of genes. Many transcriptional events that mediate adipogenesis have been elucidated in cell lines, particularly in 3T3-L1 cells (22, 24) . The primary regulators include the CCAAT/enhancer binding proteins (C/EBP␤, C/EBP␦, and C/EBP␣) and peroxisome proliferator-activated receptor ␥2 (PPAR␥2), a member of the nuclear receptor (NR) family of transcription factors (22) . These factors seem to have similar roles in both white and brown adipocyte differentiation. Little is known about the potential interconversion of white and brown adipose tissue in terms of whether specific white or brown preadipocytes give rise to each type of adipose tissue or whether a single preadipocyte may be able to differentiate into either form of adipose cell. However, a number of transcription factors, coactivators, and cell cycle regulators, including NRs and NR cofactors, have been implicated in the control of white and brown adipocyte differentiation (30) . One key regulator of many metabolic processes is the PPAR␥ coactivator 1␣ (PGC1␣), which is required for adaptation to metabolic and physiologic stimuli (18, 20, 27) . PGC1␣ coordinates a number of signaling pathways in adipocytes, including those involving additional coactivators for NRs, such as the p160 family members SRC-1 and TIF2. The relative expression levels of these coactivators regulate the development and functions of WAT and BAT (26) .
The role of NR corepressors in adipogenesis and adipocyte function is less well understood. The corepressor RIP140 binds to the ligand binding domain of NRs in the presence of agonists, and lack of RIP140 results in reduced fat accumulation in vivo (17) . The aim of this study was to determine the intrinsic role of RIP140 in adipose biology by using differentiated wildtype and RIP140-null primary adipogenic cultures, a RIP140-null cell line that retains its ability to undergo adipogenesis, and cells into which RIP140 has been reintroduced. Comparison of gene expression profiles in undifferentiated cells and adipocytes lacking and expressing RIP140 identifies derepressed and repressed genes that contribute to adipocyte function.
Chromatin immunoprecipitation (ChIP) assay. Cells were incubated in the protein-protein cross-linking reagent dimethyl adipimidate · 2HCl (Pierce) at 10 mM in PBS for 30 min, followed by incubation in 1% formaldehyde in DMEM for 5 min at 37°C. The cross-linked cells were lysed, sonicated, and immunoprecipitated with protein A/G PLUS-agarose (Santa Cruz) according to the manufacturer's instructions using mouse anti-V5 antibody (Invitrogen) or control normal mouse IgG (Santa Cruz). DNA fragments were purified with a QIAquick PCR purification kit (QIAGEN) and used for templates in PCRs.
Affymetrix array hybridization and data analysis. Total RNA was isolated from three samples each of RIPKO-1 and RIPKO-L cells, both undifferentiated and after adipocyte differentiation (10 days) in the presence of the PPAR␥ ligand GW1929 (2.5 m) (Sigma). Two RIP140-lentivirus-transduced cell lines were used for profiling in order to avoid variation due to differences in the sites of incorporation of the virus. Affymetrix array hybridization and scanning were performed by the CSC/IC Microarray Centre, Imperial College London, Hammersmith Campus, using murine 430 2.0 chips. Array data were analyzed with d-CHIP software (19) . The microarray data are available at http://www.ebi.ac.uk/ arrayexpress/ under accession number E-MIMR-42.
RESULTS
Adipogenesis of wild-type and RIP140-null cells. To investigate the intrinsic role of RIP140 in adipocytes, primary cultures of WAT and MEFs were induced to differentiate with a standard hormone cocktail in the absence or presence of the PPAR␥ agonist rosiglitazone. In these primary cell systems, both wild-type and RIP140-null cells underwent adipogenesis, as judged morphologically by the accumulation of cytosolic fat droplets (data not shown). In addition to these changes, the induction of the adipocyte marker aP2 gene and the adipocyte transcription factor PPAR␥2 was detected in all cell types following differentiation (Fig. 1A and B) .
The absence of RIP140 in mice results in altered expression in adipose tissue of key genes involved in energy metabolism, including Ucp1 and the carnitine palmitoyltransferase 1b gene (Cpt1b); however, the signaling mechanisms in vivo are complex, involving intrinsic and systemic factors. We therefore analyzed the expression levels of these genes in the cell culture systems. Ucp1 and Cpt1b were more highly expressed in primary cultures of WAT and MEFs devoid of RIP140, with expression levels being dependent on differentiation ( Fig. 1A and B).
We generated a MEF line lacking the RIP140 gene (termed RIPKO-1) by continuous culturing of the primary MEFs. This cell line retained the potential to differentiate into adipocytes, as judged morphologically by cytosolic fat droplet accumulation (data not shown). Consistent with these changes, aP2 and PPAR␥ were induced in the cells, with maximal expression being reached by day 6 of treatment ( Fig. 1C, upper panel) . Ucp1 and Cpt1b displayed progressive increases in expression in the RIPKO-1 cells (Fig. 1C, lower panel) . The expression of Ucp1 in BAT is normally associated with the transcription factor PGC1␣. However, expression levels of PGC1␣ or of the related gene PGC1␤ were similar in wild-type and RIP140-null primary WAT adipocytes (data not shown).
Identification of RIP140 target genes following reexpression of RIP140 in RIPKO-1 cells. To verify an essential role for RIP140 in gene regulation, it was reexpressed in the RIPKO-1 cells using a lentiviral vector. Adipocyte differentiation of stably expressing cell lines (termed RIPKO-L cells) was unaltered compared to that of the parental null cells, as determined by oil red O staining ( Fig. 2A) . Furthermore, both aP2 and PPAR␥2 gene expression levels were progressively increased during dif- (Fig. 2B) . However, the patterns of expression differed between the cell lines; expression increased in 3T3-L1 cells following differentiation, whereas in RIPKO-L cells, expression was reduced. This difference is due to the reintroduced RIP140 being under the control of the cytomegalovirus promoter rather than that of its endogenous regulatory mechanisms.
To identify genes that, in adipocytes, are targeted for regulation by RIP140, we performed expression profiling using Affymetrix microarrays. Gene expression in RIPKO-1 cells was compared to that in cells in which RIP140 had been reintroduced with a lentiviral vector. The transcription factors C/EBP␣, PPAR␥, and SREBP1, which are essential for normal adipocyte differentiation and function, were induced following differentiation in both RIPKO-1 and RIPKO-L cells (Fig. 2C , upper panel). Genes that are associated with adipocyte function, such as those for SCD1, aP2, and adipsin, were also induced.
The microarray data were analyzed to identify genes that are induced in mature adipocytes and may be targeted for repression by RIP140. We selected genes that are upregulated by at least twofold in RIPKO-1 cells upon differentiation yet are repressed fivefold upon RIP140 reexpression (Fig. 2C , middle panel). The Ucp1 gene was identified within this gene cluster, showing that the reexpression of RIP140 in RIPKO-1 cells ablates the adipocyte-dependent expression of this gene. This analysis identified a number of additional genes repressed by the reexpression of RIP140 (Fig. 2C, middle panel) . These include genes implicated in adipocyte function, namely, the Cidea (cell-death-inducing DFF45-like effector A) (41), Aquaporin 7 (AQPap) (13), ␤3-adrenergic receptor (2), carboxylesterase 3 (34), acetyl coenzyme A synthetase 2 (33), and membrane metalloendopeptidase (31) genes. In addition, a number of other genes are similarly repressed by RIP140 expression (Fig. 2C, middle panel) . In contrast, the expression levels of key regulators and markers of BAT function (37) are unaltered or only moderately affected (Fig. 2C, lower panel) . For example, PGC1␣ and FOXC2 were expressed at lower levels in RIP140-null cells.
Cidea expression is altered in RIP140 ؊/؊ cells in vitro and in vivo. We next investigated the regulation of the Cidea gene, identified by the microarray study as highly expressed only in differentiated RIPKO-1 cells, which has been implicated in thermogenesis through the direct modulation of Ucp1 activity (41) . Cidea mRNA expression was undetectable in RIPKO-1, RIPKO-L, and 3T3-L1 adipocytes prior to differentiation and, following adipogenesis, increased only in RIP140-null cells (Fig. 3A, left panel) ; the expression profile closely resembled that of Ucp1 (Fig. 4A) .
To confirm these changes, we determined the expression patterns of Cidea in primary adipocyte culture systems and in vivo. Cidea was undetectable in undifferentiated primary MEFs and induced only in the RIP140-null cells (Fig. 3A, right  panel) . A similar pattern was also observed in primary WAT cultures (data not shown). Quantitative analysis of Cidea expression showed a 15-fold increase in WAT in RIP140-null mice relative to wild-type mice (Fig. 3B) . Immunohistochemical staining revealed that the expression of Cidea in unilocular adipocytes in WAT of RIP140 Ϫ/Ϫ mice (Fig. 3B ) localized predominantly in the cytoplasmic area near the plasma membrane, similarly to Ucp1.
RIP140 targets the Ucp1 promoter to repress transcription. To investigate further the mechanism of action of RIP140, we analyzed its ability to repress transcription from the Ucp1 promoter. Real-time PCR showed that Ucp1 expression was reduced in RIPKO-1 cells upon exogenous RIP140 expression to generate the RIPKO-L cells (Fig. 4A ). Western blot analysis showed an induction of a 32-kDa immunoreactive band corresponding to UCP1 in fully differentiated RIP140-null cells (Fig. 4B) . Immunocytochemical staining of RIPKO-1 cells showed a progressive increase in UCP1 as differentiation proceeded (Fig. 4B ). This staining verified that UCP1 was confined to the lipid-containing differentiated cells and localized to the cytoplasm in accordance with its role as a protein confined to the mitochondrial compartment.
In mouse brown adipocytes, the transcription from the Ucp1 gene promoter is under the control of a region up to 4 kb upstream of the transcriptional start site (4, 16) . Subsequent studies with transgenic mice have identified a 220-bp enhancer from kb Ϫ2.5 to Ϫ2.3 that controls tissue-specific expression (32) . RIPKO-1 cells were transiently transfected with a luciferase reporter gene under the control of either the wild-type 4-kb Ucp1 promoter or a construct with the 220-bp enhancer region deleted (4kb⌬Enh). Reporter activity was reduced by 50% with the deletion of the enhancer element (Fig. 4C) . Exogenous expression of RIP140 inhibited luciferase activity from both the wild-type and 4kb⌬Enh constructs. Following the demonstration that the enhancer region was necessary for the full induction of Ucp1 promoter activity, RIPKO-1 cells were transiently transfected with a luciferase reporter gene under the control of either the 4-kb Ucp1 promoter or the 220-bp enhancer element linked to the thymidine kinase promoter from Ϫ105 to ϩ50. There was a progressive increase in promoter activity as the cells differentiated. Coexpression of RIP140 inhibited the Ucp1 promoter activity from both the full-length promoter and the 220-bp enhancer element, thus identifying this specific region as a target for RIP140 suppression of Ucp1 gene transcription (Fig. 4D) .
Direct association of RIP140 with the Ucp1 enhancer element was determined using ChIP assays. The expression of RIP140-V5 in the RIPKO-L cells does not exceed that of the endogenous RIP140 in differentiated 3T3-L1 adipocytes (Fig.  2B ). An antibody specific for V5 precipitated the Ucp1 enhancer element in differentiated RIPKO-L cells but not a control region 15 kb upstream of the mouse Ucp1 gene (Fig. 4E) . Enrichment of the Ucp1 enhancer element was not observed with the V5 antibody in RIPKO-1 cells devoid of RIP140. Thus, RIP140 is recruited to the Ucp1 enhancer element in differentiated RIPKO-L cells.
Increased ␤-oxidation in RIP140-null adipocytes. Following the identification of the Ucp1 gene as a target for RIP140, we investigated the functional consequences of increased Ucp1 expression. The induction of factors that facilitate fatty acid (Fig. 5A) . The cells had differentiated to similar extents, as judged by the expression of aP2; however, Ucp1 levels were elevated in the RIP140-null adipocytes (Fig. 5A) . Measurement of the ratio of mitochondrial DNA to nuclear DNA in primary MEFs showed that mitochondrial biogenesis occurred in both wild-type and RIP140-null cells following differentiation (Fig. 5A) . However, the absence of RIP140 did not significantly affect the level of mitochondrial DNA in the differentiated cells. The specific uptake of a MitoTracker mitochondrion-selective probe revealed that both RIPKO-1 and RIPKO-L differentiated cells contained more mitochondria than undifferentiated cells did (Fig. 5B ).
The rate of 3 H 2 O production derived from [ 3 H]palmitic acid was determined in RIPKO-1, RIPKO-L, and 3T3-L1 cells that were differentiated to similar extents, as judged by aP2 expression (Fig. 5C ). RIP140-null adipocytes exhibited total fatty acid oxidation levels twofold higher than those of wild-type 3T3-L1 adipocytes, and this level was repressed by the reexpression of RIP140 (Fig. 5C ). The potential to prevent the induction of the expression of genes involved in energy dissipation demonstrates a primary role for RIP140 in this process and provides a mechanism for regulating ␤-oxidation within adipose cells.
DISCUSSION
Adipogenesis and adipocyte functions in vivo are regulated by multiple mechanisms that involve combinations of cell-autonomous and systemic factors. To study the intrinsic role of RIP140 in adipocytes, we differentiated primary WAT cells, MEFs, and a RIP140-null cell line. In particular, the RIP140-null cells (RIPKO-1) and cell lines derived from it in which RIP140 is reexpressed (RIPKO-L) provide systems for elucidating the cell-autonomous mechanisms by which this corepressor regulates the expression of target genes involved in energy dissipation. In microarray analysis of both cell types, key regulators and markers of the adipogenic cascade, including PPAR␥, C/EBP␣, SCD1, aP2, and adipsin, are induced. Thus, the adipogenic program is not perturbed either by the absence of or by the exogenous expression of RIP140.
Affymetrix microarray analysis was used to identify genes that are targeted for repression by RIP140 in mature adipocytes. These studies confirm the in vivo observations that Ucp1, a key factor in energy expenditure in BAT which is upregulated in the WAT in RIP140-null mice, is also derepressed following the loss of RIP140 in isolated adipocytes. The Cpt1b gene, which was also shown to be elevated in expression in vivo, is similarly increased in null cells, but to a lesser extent than Ucp1 is. In addition to Ucp1, we identified a number of genes regulated with similar expression profiles. These include the gene encoding Cidea, a protein reported to interact directly with Ucp1 to modulate the process of thermogenesis (41), which is downregulated by obesity in human WAT (23) . We hypothesize therefore that RIP140 may be directly involved in the prevention of the expression of genes such as those encoding UCP1, CPT1b, and Cidea. In particular, the demonstration that novel RIP140 targets such as Cidea are derepressed in primary cells, mouse embryo fibroblasts, and in vivo WAT provides evidence to validate the expression profile differences determined by the microarray studies. The increased Ucp1, Cpt1b, and Cidea expression in the absence of RIP140 occurs progressively during differentiation, suggesting that it is dependent on factors generated during adipogenesis. This progressive increase was also observed when transcription from a transfected Ucp1 gene promoter was analyzed for RIPKO-1 cells. The upregulation seems to be mediated predominantly by a previously characterized 220-bp enhancer element in the promoter containing binding sites for PPARs and TR/RXR (1, 29, 32) . Importantly, we found that this element was a target for repression by RIP140 in transfected RIPKO-1 cells. This was further confirmed using ChIP experiments, demonstrating that RIP140 is recruited directly to this regulatory element in differentiated RIPKO-L cells where Ucp1 expression is abrogated. In brown fat cells, PPARs, together with PGC-1␣, have been shown to stimulate transcription from the Ucp1 promoter (1, 28, 32) . Ucp1 expression is also regulated by neural signals under the control of the sympathetic nervous system that result in the activation of transcription factors such as ATF2 (2, 3) . The levels of PGC-1␣ and PGC-1␤ did not differ between wild-type and RIP140-null adipocytes, suggesting that altered expression of these coactivators is not essential for Ucp1 expression in the absence of RIP140.
In addition to the Ucp1 gene, a number of other genes are regulated with similar expression profiles, many of which are expressed in adipocytes and may also be nuclear receptor targets, including the AQPap gene, encoding a protein forming adipose-specific glycerol channels (14) . Whether such genes are also direct targets of RIP140 or are regulated indirectly by additional factors is still to be determined. In contrast, other genes implicated in BAT function, such as the FOXC2 gene, were not increased in cells lacking RIP140. It is apparent that the absence of RIP140 in adipose cells results in increased levels of a subset of genes normally restricted to BAT, some of which regulate metabolic uncoupling processes and hence energy expenditure.
It is noteworthy that the abilities of primary MEFs and 3T3-L1, RIPKO-1, and RIPKO-L cells to metabolize palmitate correlated with the expression levels of Ucp1, Cpt1b, and Ci- (40); however, the degrees of mitochondrial biogenesis did not differ significantly between wild-type adipocytes and those null for the RIP140 gene. The increased number of mitochondria in differentiated cells, along with the elevation of Ucp1, provides increased capacity for the enhanced ␤-oxidation in cells lacking RIP140. These data demonstrating altered gene expression and mitochondrial respiration in RIP140-null adipocytes are in agreement with both expression-profiling studies and the increased O 2 consumption in vivo found in RIP140-null mice (17) . Our studies demonstrate that processes that control metabolism and energy homeostasis in the adipocyte involve the direct action of a ligand-dependent NR corepressor and are independent of systemic effects. In summary, it has been demonstrated by a number of studies that NRs and their coactivators, by integrating different hormonal signals to regulate gene expression, play a fundamental role in the regulation of both the differentiation and the metabolic function of adipocytes. Here we describe a major role in adipocytes for a liganddependent NR corepressor in the prevention of the expression of genes that are associated with energy dissipation. Therefore, the prevention of RIP140 recruitment to receptors or a reduction in the levels of RIP140 itself may provide novel mechanisms for the control of energy use in adipose cells and assist in the treatment of obesity-related disorders.
